A virulent phage JHP against Pseudomonas aeruginosa showed infectivity against multiple genera
Komal Ameer Khawaja1, Mahd Rauf1, Zaigham Abbas1
1Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.
Abstract:
The resistance to antibiotics in clinically important bacteria is one of the major global health concerns. Phage therapy could be one reliable alternative therapeutic strategy to combat these superbugs. In this study, we assessed host range of a novel bacteriophage, JHP, and characterized for its potential use in phage therapy. The bacteriophage demonstrated infectivity over a broad range of genera including multidrug resistant clinical isolates of Pseudomonas aeruginosa, members of family Enterobacteracae, and other important human pathogens. The antibacterial activity was highest at pH 7, and at temperature of 37 °C. The phage lytic activity gradually decreased till 60 °C and showed no activity when temperature was further raised. The bacteriophage could safely be stored at 4 °C or -20 °C. The latent period of the bacteriophage was 25 min and showed a burst size of 433 virions per cell. The size of JHP genome was approximately 30 kb. Family, Siphoviridae was assigned to JHP based on its icosahedral head with non-contractile tail. The diameter of JHP head and tail length was found 115 and 152 nm, respectively. To sum up, the broad spectrum Siphoviridae phage JHP is an ingenious candidate for phage therapy.
Insights
Phage therapy offers a promising alternative to antibiotics against resistant bacteria. A novel Siphoviridae bacteriophage, JHP, shows broad-spectrum activity against pathogens like Pseudomonas aeruginosa and Enterobacteriaceae.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Antibiotic resistance in bacteria is a critical global health issue.
- Bacteriophage therapy presents a viable alternative to combat multidrug-resistant pathogens.
- Novel bacteriophages require characterization for therapeutic potential.
Purpose of the Study:
- To evaluate the host range and characteristics of a novel bacteriophage, JHP.
- To assess the suitability of bacteriophage JHP for phage therapy applications.
Main Methods:
- Assessed bacteriophage JHP infectivity against various bacterial genera, including multidrug-resistant clinical isolates.
- Determined optimal conditions (pH, temperature) for antibacterial activity and storage.
- Characterized JHP's lytic properties, genome size, and morphology (Siphoviridae family).
Main Results:
- Bacteriophage JHP exhibited broad-spectrum infectivity against Pseudomonas aeruginosa, Enterobacteriaceae, and other human pathogens.
- Optimal activity occurred at pH 7 and 37°C; stable storage at 4°C or -20°C.
- JHP has a latent period of 25 min, burst size of 433 virions/cell, a ~30 kb genome, and Siphoviridae morphology (115 nm head, 152 nm tail).
Conclusions:
- The broad-spectrum Siphoviridae bacteriophage JHP is a promising candidate for phage therapy.
- JHP demonstrates significant potential in combating antibiotic-resistant bacterial infections.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Lytic Cycle of Bacteriophages
Regulation of Bacterial Virulence
Viral Replication: Lysogenic Cycle
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages


